FUSCO, NICOLA
FUSCO, NICOLA
Dipartimento di Oncologia ed Emato-Oncologia
Concurrent presence of primary hemangioma and breast cancer metastasis within a lymph node: a case report inspired by the legacy of Professor Juan Rosai
2024 M. Ivanova, M. D'Ercole, F.M. Porta, B. Di Venosa, C. Frascarelli, C. Di Bella, F. Pagni, E. Guerini-Rocco, N. Fusco
Contrast-Enhanced Mammography (CEM) compared to Breast Magnetic Resonance (MRI) in the evaluation of breast lobular neoplasia
2024 L. Nicosia, A. Rotili, F. Pesapane, A.C. Bozzini, O. Battaglia, G. Pellegrino, N. Fusco, F.M. Porta, S. Frassoni, V. Bagnardi, G. Corso, C. Sangalli, E. Cassano
Digital pathology applications for PD-L1 scoring in head and neck squamous cell carcinoma: a challenging series
2024 V. Canini, A. Eccher, G. D'Amati, N. Fusco, F. Maffini, D. Lepanto, M. Martini, G. Cazzaniga, P. Paliogiannis, R. Lobrano, V. L'Imperio, F. Pagni
The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy
2024 K. Venetis, C. Pescia, G. Cursano, C. Frascarelli, E. Mane, E. De Camilli, E. Munzone, S. Dellapasqua, C. Criscitiello, G. Curigliano, E. Guerini Rocco, N. Fusco
Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence
2024 M. Ivanova, C. Pescia, D. Trapani, K. Venetis, C. Frascarelli, E. Mane, G. Cursano, E. Sajjadi, C. Scatena, B. Cerbelli, G. D'Amati, F.M. Porta, E. Guerini-Rocco, C. Criscitiello, G. Curigliano, N. Fusco
Comprehensive Pulmonary Rehabilitation for Patients with Malignant Pleural Mesothelioma: A Feasibility Pilot Study
2024 L. Lippi, A. de Sire, A. Folli, C. Curci, D. Calafiore, M. Lombardi, L. Bertolaccini, A. Turco, A. Ammendolia, N. Fusco, L. Spaggiari, M. Invernizzi
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories
2024 F. Pepe, K. Venetis, G. Cursano, C. Frascarelli, P. Pisapia, D. Vacirca, C. Scimone, A. Rappa, G. Russo, E. Mane, F. Pagni, I. Castellano, G. Troncone, C.D. Angelis, G. Curigliano, E. Guerini-Rocco, U. Malapelle, N. Fusco
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer
2024 M. Ivanova, F.M. Porta, M. D'Ercole, C. Pescia, E. Sajjadi, G. Cursano, E. De Camilli, O. Pala, G. Mazzarol, K. Venetis, E. Guerini-Rocco, G. Curigliano, G. Viale, N. Fusco
PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores
2024 M. Ivanova, C. Frascarelli, B. Cerbelli, M.G. Pignataro, A. Pernazza, K. Venetis, E. Sajjadi, C. Criscitiello, G. Curigliano, E. Guerini-Rocco, P. Graziano, M. Martini, G. D'Amati, N. Fusco
Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment
2024 G. Corso, N. Fusco, E. Guerini-Rocco, M.C. Leonardi, C. Criscitiello, P. Zagami, E. Nicolo, G. Mazzarol, C. La Vecchia, F. Pesapane, C. Zanzottera, P. Tarantino, S. Petitto, B. Bianchi, G. Massari, A. Boato, A. Sibilio, A. Polizzi, G. Curigliano, A.M. De Scalzi, F. Lauria, B. Bonanni, M. Marabelli, A. Rotili, L. Nicosia, A. Albini, M. Calvello, R.A. Mukhtar, M.E. Robson, V. Sacchini, G. Rennert, V. Galimberti, P. Veronesi, F. Magnoni
Immune and Gene-expression Profiling in Estrogen Receptor Low and Negative Early Breast Cancer
2024 D. Massa, C. Vernieri, L. Nicolè, C. Criscitiello, F. Boissière-Michot, S. Guiu, A. Bobrie, G. Griguolo, F. Miglietta, A. Vingiani, R. Lobefaro, B. Taurelli Salimbeni, C. Pinato, F. Schiavi, S. Brich, C. Pescia, N. Fusco, G. Pruneri, M. Fassan, G. Curigliano, V. Guarneri, W. Jacot, M.V. Dieci
A Phase 3 Prospective Randomized Trial to Evaluate the Impact of Augmented Reality During Robot-assisted Radical Prostatectomy on the Rates of Postoperativane Surgical Margins: A Clinical Trial Protocol
2024 G. Musi, F.A. Mistretta, O. de Cobelli, A. Bellin, G.G. Vago, G. Pravettoni, D. Bottero, M.L. Piccinelli, M. Ferro, M. Ivanova, G. Petralia, G. Marvaso, B.A. Jereczek-Fossa, V. Bagnardi, G. Renne, N. Fusco, S. Luzzago
Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer
2024 E. Guerini-Rocco, K. Venetis, G. Cursano, E. Mane, C. Frascarelli, F. Pepe, M. Negrelli, E. Olmeda, D. Vacirca, A. Ranghiero, D. Trapani, C. Criscitiello, G. Curigliano, C. Rolfo, U. Malapelle, N. Fusco
Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management
2023 M. Ivanova, F.M. Porta, F. Giugliano, C. Frascarelli, E. Sajjadi, K. Venetis, G. Cursano, G. Mazzarol, E. GUERINI ROCCO, G. Curigliano, C. Criscitiello, N. Fusco
Malignancies in Patients with Celiac Disease: Diagnostic Challenges and Molecular Advances
2023 M. Ivanova, L. Bottiglieri, E. Sajjadi, K. Venetis, N. Fusco
Diagnostic performance of image-guided vacuum-assisted breast biopsy after neoadjuvant therapy for breast cancer: prospective pilot study
2023 E.M.C. Rossi, A. Invento, F. Pesapane, E. Pagan, V. Bagnardi, N. Fusco, K. Venetis, V. Dominelli, C. Trentin, E. Cassano, L. Gilardi, M. Mazza, M. Lazzeroni, F. De Lorenzi, P. Caldarella, A. De Scalzi, A. Girardi, C. Sangalli, L. Alberti, V. Sacchini, V. Galimberti, P. Veronesi
Editorial : Diagnosis and Treatment of Breast Cancer in 2022 : The Rise of Novel Molecular Biomarkers
2023 N. Fusco, U. Malapelle, C. Criscitiello
HER2 Testing in Breast and Gastric Cancer with CDH1 Germline Mutations
2023 M. Ivanova, E. Sajjadi, L. Zattoni, N. Fusco
Unlocking the Resistance to Anti-HER2 Treatments in Breast Cancer: The Issue of HER2 Spatial Distribution
2023 F. Giugliano, A. Carnevale Schianca, C. Corti, M. Ivanova, N. Bianco, S. Dellapasqua, C. Criscitiello, N. Fusco, G. Curigliano, E. Munzone
Artificial intelligence-based tools applied to pathological diagnosis of microbiological diseases
2023 S. Marletta, V. L'Imperio, A. Eccher, P. Antonini, N. Santonicco, I. Girolami, A.P.D. Tos, M. Sbaraglia, F. Pagni, M. Brunelli, A. Marino, A. Scarpa, E. Munari, N. Fusco, L. Pantanowitz